July 2014 Deals & Suits
Novartis AG announced a major asset swap with GlaxoSmithKline plc as well as a agreement to sell its animal health unit to Eli Lilly & Co. on April 22. All told, the deals could be worth more than $30 billion.
This content has been archived. It is available exclusively through our partner LexisNexis®.
To view this content, please continue to Lexis Advance®.
Not a Lexis Advance® Subscriber? Subscribe Now
For questions call 1-877-256-2472 or contact us at email@example.com